Literature DB >> 12405651

Contribution of the raw material to the aluminum contamination in parenterals.

Denise Bohrer1, Paulo Cícero do Nascimento, Regina Binotto, Emilene Becker, Solange Pomblum.   

Abstract

BACKGROUND: The extent of aluminum contamination in parenteral nutrition solutions was measured in 35 different commercial products, including amino acids, electrolytes, glucose, lipids, vitamins trace elements, and albumin. The extent of aluminum contamination in substances used as raw material for preparation of parenterals was also measured. Chemicals from different manufacturers and of different quality grades were analyzed individually.
METHODS: The measurements were done by atomic absorption spectrometry.
RESULTS: The results showed that the same product might have different aluminum content depending on the manufacturer, either for commercial formulations or substances. The highest contaminated chemicals included cystine, NaOH, vitamin C, biotin, gluconate, and Fe and Cr salts. The lowest contaminated chemicals included lipids, apolar amino acids, glucose, HCI, acetic acid, KCl, NaCl, and heparin. Among commercial products, the major contamination rates appeared in calcium gluconate, followed by trace elements, some vitamins, bicarbonate, phosphates salts, and heparin.
CONCLUSIONS: Comparing the aluminum in commercial products and substances, it can be concluded that the contamination may occur in parenterals because aluminum is present naturally in the chemicals. However, when the composition and concentration of the parenteral solution are considered, the contamination of calcium gluconate, trace elements, some vitamins, phosphates, bicarbonate, and heparin cannot be related only to the raw substances. The aluminum level present in these commercial formulations is too high to come only from the substances; therefore, it is possible that one of the steps of the manufacturing procedure is responsible for elevating the contamination of these products.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405651     DOI: 10.1177/0148607102026006382

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  7 in total

Review 1.  Metabolic and catheter complications of parenteral nutrition.

Authors:  Marwan S Ghabril; Jamie Aranda-Michel; James S Scolapio
Journal:  Curr Gastroenterol Rep       Date:  2004-08

2.  Aluminum in pediatric parenteral nutrition products: measured versus labeled content.

Authors:  Robert L Poole; Kevin P Pieroni; Shabnam Gaskari; Tessa K Dixon; Kt Park; John A Kerner
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

3.  Ion-exchange and potentiometric characterization of Al-cystine and Al-cysteine complexes.

Authors:  Denise Bohrer; Vania Gabbi Polli; Paulo Cícero do Nascimento; Jean Karlo A Mendonça; Leandro Machado de Carvalho; Solange Garcia Pomblum
Journal:  J Biol Inorg Chem       Date:  2006-08-24       Impact factor: 3.358

Review 4.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

5.  Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology.

Authors:  Robert K Huston; J Mark Christensen; Sultan M Alshahrani; Sumeia M Mohamed; Sara M Clark; Jeffrey A Nason; Ying Xing Wu
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Aluminum exposure in neonatal patients using the least contaminated parenteral nutrition solution products.

Authors:  Robert L Poole; Kevin P Pieroni; Shabnam Gaskari; Tessa Dixon; John A Kerner
Journal:  Nutrients       Date:  2012-11-02       Impact factor: 5.717

7.  Calcium chloride in neonatal parenteral nutrition: compatibility studies using laser methodology.

Authors:  Robert K Huston; J Mark Christensen; Chanida Karnpracha; Jill E Rosa; Sara M Clark; Evelyn A Migaki; YingXing Wu
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.